<DOC>
	<DOCNO>NCT00668317</DOCNO>
	<brief_summary>The study aim determine effect 8 week anti-reflux treatment ( full acid suppression ) bronchial hyper-responsiveness whether symptomatic improvement .</brief_summary>
	<brief_title>Bronchial Hyper-responsiveness Reflux Cough</brief_title>
	<detailed_description />
	<mesh_term>Cough</mesh_term>
	<mesh_term>Bronchial Hyperreactivity</mesh_term>
	<mesh_term>Omeprazole</mesh_term>
	<mesh_term>Ranitidine</mesh_term>
	<mesh_term>Ranitidine bismuth citrate</mesh_term>
	<criteria>Positive methacholine challenge test PC20 le 4mg/ml ( Can previously document patient note within last 4weeks ) Written informed consent Patients history chronic cough ( least 3 month duration ) , associate symptom gastrooesophageal reflux Male female subject least 18 yrs age Subjects able perform satisfactory FEV1 manoeuvre Subjects able understand study cooperate study procedure Subjects consent general practitioner ( GP ) inform study participation heart attack last three month suffers angina , hypertension ischaemic heart disease epilepsy he/she take medication FEV1 &lt; 60 % predict FEV1 &lt; 1.6L Female subject pregnant , lactating , child bear potential use contraceptive measure Suffering concomitant disease may interfere study procedure evaluation . A low respiratory tract infection 4 week prior entry study Participation another study ( use investigational product ) within 30 day precede entry study . Alcohol drug abuse Use opiates treat cough 1 week prior enrollment Subjects take Angiotensin Converting Enzymes ( ACE ) inhibitor . Subjects significant pathology recent chest XRay . Inability understand procedure implication challenge test Patients already take take last 4 week PPI H2 receptor antagonist ( full acid suppression treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>October 2012</verification_date>
	<keyword>Hyper-responsiveness , reflux cough</keyword>
</DOC>